> investor relations / Empowering Your Healthspan
Built for the Long Run.
Empowering Your Healthspan is a multi-decade platform, not a momentum trade — measured in member trust and longitudinal fidelity, not quarters.
Engaging America’s senior intelligence to build a smarter, healthier world.
Capital formation timeline
We empower healthspan — extending the years people live at peak cognitive and physical capacity, not just the years they live.
We’re building toward a future where keeping people young is a category, not an aspiration.
Our first institutional round opens in November 2026, targeting $2.5M to fund team expansion and go-to-market.
We are intentionally pre-round through Q3 2026. The capital we raise should compound the platform we have already built — not subsidize the search for one. That sequence is deliberate: product-market fit before price discovery.
What we’re looking for
Investors who believe the Health Singularity is a real and investable thesis — that the convergence of AI, biometrics, cognitive training, and longevity science is producing a generational category, and that the founding teams who define it now will own it for the next decade.
If that’s you, we’d like to talk early.
Revenue architecture — two streams, one discipline
Subscription receipts and sponsor funds are separated at the outset. The chart below is not illustrative — it mirrors how flows are routed and disclosed.
Company revenue
Monthly subscription fees paid by members of the Empowering Your Healthspan platform.
Recurring. Predictable. Aligned with the people we serve.
Partner pass-through (not company revenue)
Payments received from research institutes, pharmaceutical companies, medical-device manufacturers, supplement brands, and longevity researchers in connection with cohort studies conducted on the platform.
These funds are partner funds. They are not booked as company revenue.
The company retains a fixed 8% administration fee. The remainder is remitted to the partner conducting the study.
Member subscriptions fund Got-Data Inc. Research sponsorships fund the research partners. The two are kept separate by design.
The thesis — America’s senior intelligence dividend
The 60–90 cohort is the most underutilized reserve of cognition, experience, and longitudinal data in the modern economy. Most platforms treat this population as a cost center; we treat it as an asset class.
A coordinated, opt-in, longitudinally-tracked national cohort of engaged seniors becomes a research instrument — not a research subject. Trained attention, biometric continuity, and decades of pattern recognition compound into a dataset that no demographic in human history has ever produced.
America’s edge in the AI century will not come only from silicon or capital. It will come from the lived intelligence of the generation that built the modern economy — and from the institutions wise enough to keep them in the game.
Empowering Your Healthspan is the connective tissue: strength training, cognitive training (BrainHQ-class protocols), biometric tracking, sleep optimization, and cohort participation — assembled into a platform where aging stops being a tax on the country and starts being a contribution to it.
“Seniors are not a problem to be managed. They are an asset to be activated.”
“A nation that wastes its elders forfeits its memory. A nation that engages them compounds it.”
Governance & discipline
- Strict separation between subscription revenue and partner pass-through funds, with independent ledgers.
- Administration fee fixed at 8% and publicly disclosed.
- No paid placement in cohort selection or partner ranking.
- Annual transparency report planned beginning fiscal year following first round.
- Member data sovereignty: members own their data; partners license access on per-study terms.
This page is informational only. It does not constitute an offer to sell, or a solicitation of an offer to buy, any security. Any future capital round will be conducted in accordance with applicable U.S. federal and state securities laws. Statements regarding future plans, timing, and outcomes are forward-looking and subject to risks and uncertainties; actual results may differ materially.